Published on Medical Design Technology (http://www.mdtmag.com)

Home > Cellceutix to launch phase 1 trial for cancer drug

Cellceutix to launch phase 1 trial for cancer drug

Mass High Tech: The Journal of New England Technology

Cellceutix Corporation (OTCBB: CTIX) will launch its first human trial for its lead product, a potential therapy for advanced solid tumors at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, after a nine-month delay.

Source URL (retrieved on 05/25/2013 - 7:28pm): http://www.mdtmag.com/news/2012/09/cellceutix-launch-phase-1-trial-cancer-drug